Promotional efforts directed toward prescribing physician as affecting prescription drug manufacturer’s liability for product-caused injury, 94 A.L.R.3d 1080.
What is “device” within meaning of § 201(h) of Federal Food, Drug, and Cosmetic Act (21 USCS § 321(h)), 129 A.L.R. Fed. 343.
What is “new drug” within meaning of § 201(p) of Federal Food, Drug, and Cosmetic Act (21 USCS § 321(p)), 133 A.L.R. Fed. 229.
The following acts and the causing thereof within this state are
prohibited:
(1) The manufacture, sale or delivery, or holding or offering for sale of any drug, device, or cosmetic that is adulterated or mis-
branded;
(1.1) The holding of any drug, device, or cosmetic that is adulter-
ated or misbranded;
(2) The adulteration or misbranding of any drug, device, or
cosmetic;
(3) The receipt in commerce of any drug, device, or cosmetic that is adulterated or misbranded and the delivery or proffered delivery
thereof for pay or otherwise;
(4) The sale, delivery for sale, holding for sale, or offering for sale of any article in violation of Code Section 26-3-10;
(5) The dissemination of any false advertisement;
(6) The refusal to permit entry or inspection or to permit the taking of a sample as authorized by Code Section 26-3-17;
(7) The giving of a guarantee or undertaking which is false except
by a person who relied on a guarantee or undertaking to the same effect signed by and containing the name and address of the person residing in this state from whom he received the drug, device, or cosmetic in good faith;
(8) The removal or disposal of a detained or embargoed article in violation of Code Section 26-3-4;
(9) The alteration, mutilation, destruction, obliteration, removal
of the whole or any part of the labeling of, or the doing of any other act with respect to a drug, device, or cosmetic if such act is done while such article is held for sale and results in such article being
misbranded;
(10) Forging, counterfeiting, simulating, falsely representing, or without proper authority using any mark, stamp, tag, label, or other identification device authorized or required by regulations promulgated under this chapter; and
(11) The use on the labeling of any drug or in any advertisement relating to such drug of any representation or suggestion that any application with respect to such drug is effective under or complies
with Code Section 26-3-10.